The Food and Drug Administration is cracking down on copycat versions of Ozempic — the brand name of semaglutide — and ...

Compounding pharmacies, that produced the weight loss drugs at a fraction of their brand name price, are being forced to stop ...

GLP-1 stands for glucagon-like peptide-1, a satiety hormone the body produces when we eat to help stimulate digestion and ...

The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to ...

Providers of compounded obesity drugs are finding—for now—a new way into the booming market by tweaking formulations.

Compounded GLP-1s are no longer to be sold following the FDA announcement that the shortage of semaglutide and tirzepatide ended.

Online weight loss company Noom has begun offering smaller doses of compounded versions of Novo Nordisk's Wegovy ...

Frier Levitt will host a May 15 webinar on legal risks, compounding regulations and market trends impacting GLP-1 prescribers and pharmacies.

The maker of weight loss drugs Ozempic and Wegovy broke rules around the advertising and marketing of its medication to ...